Medacta Group SA
SIX:MOVE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medacta Group SA
SIX:MOVE
|
CH |
|
H
|
Helix Energy Solutions Group Inc
F:CTV
|
US |
|
Immunitybio Inc
F:26CA
|
US |
Wall St Price Targets
MOVE Price Targets Summary
Medacta Group SA
According to Wall Street analysts, the average 1-year price target for MOVE is 172.64 CHF with a low forecast of 152.51 CHF and a high forecast of 194.25 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MOVE's stock price target?
Price Target
172.64
CHF
According to Wall Street analysts, the average 1-year price target for MOVE is 172.64 CHF with a low forecast of 152.51 CHF and a high forecast of 194.25 CHF.
What is the Revenue forecast for Medacta Group SA?
Projected CAGR
10%
Over the last 8 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 7 years is 10%.
What is the Gross Profit forecast for Medacta Group SA?
Projected CAGR
13%
Over the last 8 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 13%.
What is the Operating Income forecast for Medacta Group SA?
Projected CAGR
11%
Over the last 8 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 7 years is 11%.
What is the Pre-Tax Income forecast for Medacta Group SA?
Projected CAGR
13%
Over the last 8 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 13%.
What is the Net Income forecast for Medacta Group SA?
Projected CAGR
11%
Over the last 8 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 3 years is 11%.
